GOCOVRI
NDC 17772-170, AMANTADINE, capsule, coated pellets, from Supernus Pharmaceuticals, Inc..
- Product NDC
- 17772-170
- Status
- Listed
- Labeler
- Supernus Pharmaceuticals, Inc.
- Dosage form
- CAPSULE, COATED PELLETS
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA208944
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/17772-170 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AMANTADINE137 mg/1
Pharmacologic classes
Influenza A M2 Protein Inhibitor [EPC]; M2 Protein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 17772-170-21 | 17772017021 | 21 CAPSULE, COATED PELLETS in 1 BOTTLE (17772-170-21) |
| 17772-170-60 | 17772017060 | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (17772-170-60) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/2bee0631-0028-1314-e063-6394a90aaaed
Use it
Look up 17772-170 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/17772-170 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 17772-170. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.